TACC1 is a multifunctional protein involved in transcription regulation and cellular organization. In normal physiology, TACC1 acts as a transcriptional coactivator for nuclear receptors, including thyroid hormone receptors and retinoic acid receptors, and may promote nuclear localization of these receptors 1. The protein is dynamically expressed during embryogenesis and differentially localized to distinct subcellular compartments in a tissue-specific manner, suggesting context-dependent functions 2. In cancer biology, TACC1 has dual roles. It functions as a tumor suppressor—TACC1 expression is downregulated in various human cancers including breast cancer, where it associates with mRNA processing regulators LSM7 and SmG, potentially affecting mRNA homeostasis 3. Conversely, TACC1 becomes oncogenic when involved in chr8 translocations. FGFR-TACC1 fusion proteins, identified in glioblastoma, uterine sarcomas, and melanoma, generate potent oncogenes combining growth promotion with aneuploidy through constitutive kinase activity 456. These fusion proteins localize to mitotic spindle poles and induce chr8 segregation defects 4. Critically, FGFR-TACC fusion-positive tumors demonstrate strong sensitivity to FGFR tyrosine kinase inhibitors, making these fusions attractive targets for precision medicine approaches 7.